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Background: Households in sub-Saharan Africa are highly reliant on the retail sector for obtaining treatment for
malaria fevers and other illnesses. As donors and governments seek to promote the use of artemisinin combination
therapy in malaria-endemic areas through subsidized anti-malarials offered in the retail sector, understanding the
stocking and pricing decisions of retail outlets is vital.
Methods: A survey of all medicine retailers serving Bungoma East District in western Kenya was conducted three
months after the launch of the AMFm subsidy in Kenya. The survey obtained information on each anti-malarial in
stock: brand name, price, sales volume, outlet characteristics and GPS co-ordinates. These data were matched to
household-level data from the Webuye Health and Demographic Surveillance System, from which population
density and fever prevalence near each shop were determined. Regression analysis was used to identify the factors
associated with retailers’ likelihood of stocking subsidized artemether lumefantrine (AL) and the association
between price and sales for AL, quinine and sulphadoxine-pyrimethamine (SP).
Results: Ninety-seven retail outlets in the study area were surveyed; 11% of outlets stocked subsidized AL. Size of
the outlet and having a pharmacist on staff were associated with greater likelihood of stocking subsidized AL. In
the multivariable model, total volume of anti-malarial sales was associated with greater likelihood of stocking
subsidized AL and competition was important; likelihood of stocking subsidized AL was considerably higher if the
nearest neighbour stocked subsidized AL. Price was a significant predictor of sales volume for all three types of
anti-malarials but the relationship varied, with the largest price sensitivity found for SP drugs.
Conclusion: The results suggest that helping small outlets overcome the constraints to stocking subsidized AL
should be a priority. Competition between retailers and prices can play an important role in greater adoption of AL.
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In sub-Saharan Africa, retail shops, pharmacies and
chemists are important sources of treatment for fevers,
including those related to malaria [1-3]. In Kenya, 17 to
83% of fevers are first treated with medicines purchased
from shops [4]. Even when treatment is eventually* Correspondence: wpo@duke.edu
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reproduction in any medium, provided the orsought in the formal health sector, a retail outlet may
be the first source of treatment. Moreover, when drugs
are not available in government health facilities, pa-
tients are generally referred to the retail sector to pur-
chase the prescribed treatment. Patients may even
bypass public facilities altogether when stock outs are
common or known.
The retail market of anti-malarials is a complex land-
scape consisting of many different wholesale-to-retail
pathways with variable numbers of links; different types
of outlets ranging from registered pharmacies to generall Ltd. This is an Open Access article distributed under the terms of the Creative
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malarials, and widely varying prices [5-8]. Within this di-
versity of choice, customer preferences and demand can
have a strong influence on shop owners’ decisions regard-
ing which drugs to stock [7,9]. Because price is a crucial
factor in patient demand, particularly in resource-limited
settings, many patients seeking treatment in the retail
sector purchase inexpensive, but ineffective, anti-malarials
rather than more expensive artemisinin combination ther-
apy (ACT) that the World Health Organization (WHO)
has recommended for treatment of uncomplicated malaria
[2,10-12].
In order to increase availability of low-cost ACT in the
retail sector, the Affordable Medicine Facility malaria
(AMFm) was introduced on a pilot basis in 2010 in eight
countries [13]. The AMFm provides high quality ACT
to wholesalers at heavily subsidized prices. Although the
programme has suggested retail prices for AMFm prod-
ucts, the retail price of the subsidized ACT is not regu-
lated; wholesalers and retailers are free to establish
prices as they would with any commodity. Only the
first-line buyers (first wholesaler) in the pilot countries
have signed price agreements to pass down subsidies.
The effectiveness of AMFm from a public health stand-
point depends on the savings being passed down to the
retailer and ultimately to the customer. An important
consideration in this regard is the complex nature of the
retail sector, which includes a large number of small-
scale outlets, a requirement for profitability, and a differ-
ent client dynamic than is found in the formal health
sector. So far there is little information in the literature
describing what factors influence anti-malarial stocking
and pricing in the retail sector.
In order to understand the potential impact of AMFm
as well as the results of the AMFm pilot, a better under-
standing of the reasons why retailers choose to stock
specific drugs and what determines the volume of differ-
ent types of drugs sold in these outlets is required.
Moreover, the sensitivity of demand to the price of drugs
is an important factor in determining the effectiveness of
the subsidy. If volume sold is unrelated to price, this
would suggest that a subsidy alone will have less of an
effect on consumer demand than other factors, for ex-
ample branding or consumer awareness.
In Kenya, the recommended ACT is artemether-
lumefantrine (AL) and the AMFm provides subsidized
AL at about 10 Kenyan shillings (KES, US$0.12) per
course with a target price to the end user of 40 KES (US
$0.50) per treatment course. A survey of all medicine re-
tailers in a district in western Kenya was conducted
shortly after the nationwide launch of AMFm. Charac-
teristics of surveyed retail outlets are described and fac-
tors associated with AL stocking decisions and sales of
different types of anti-malarials are examined.Methods
Study area
This study was conducted in the Webuye Health and
Demographic Surveillance System (HDSS) of Bungoma
East District, western Kenya. The HDSS is located in
Webuye Division. Webuye Town is approximately
80 km west of Eldoret and 50 km east of Kenya-Uganda
border. The Nairobi-Uganda highway bisects the larger
Bungoma County, thereby opening up the county for
numerous economic activities. However, most house-
holds are poor, with 52% of the population living below
the poverty line, and cannot access social amenities such
as water and electricity. The poverty line is defined as
those families living on less than 1,562 KES (~20USD)
per month. This is the minimum requirement for essen-
tial food and non-food items as defined by the Kenya
National Bureau of Statistics, Kenya Integrated House-
hold Budget Survey 2005/06. The area has a tropical cli-
mate and lies at an elevation of 1,523 m above sea level.
It experiences an average annual temperature of 24°C,
and receives high rainfall ranging from 1,200 to 1,800 mm
annually [14]. The main economic activities include sugar-
cane farming as a cash crop, while maize, sorghum and
millet are cultivated as subsistence crops. Dairy and
poultry farming are also widely practiced. The largest
paper factory in Africa and chemical processors are lo-
cated within Webuye Town [15]. The HDSS is described
in detail elsewhere [16]. Malaria burden in Bungoma East
is high, due to the suitable climate and elevation, coupled
with low coverage of insecticide-treated bed nets [17,18].
Data collection
A survey of all medicine retailers serving the HDSS was
undertaken in November 2010. Details of the survey are
reported elsewhere [7]. Briefly, a complete census of re-
tail medicine outlets that sell primarily human medicines
(excluding general stores) stocking malaria medicines
was carried out in August 2010. Outlets were included
regardless of legal registration status. Outlets that were
within 5 km of the HDSS border were included in order
to capture all outlets that may serve HDSS residents. Inter-
views were conducted with the primary shop attendant in
November 2010. The survey was carried out a few months
after the launch of the AMFm subsidy in August 2010. In-
terviewers administered the questionnaire and took a
complete inventory of anti-malarials in stock on the day of
the survey. The survey also recorded the price for a treat-
ment course of each drug, brand name, active ingredients,
and number of treatment courses sold in the past one
week. GPS co-ordinates of each retailer were also recorded.
Geographic variables
Household GPS co-ordinates were used to describe the
population density and fever prevalence around outlets
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ordinates were used to make a density raster using a ker-
nel density function with a radius of 0.5 km. The value
of the raster at the location of each outlet describes the
population density within a 0.5 km radius around each
shop. The same procedure was repeated for households
with fevers according to the most recent HDSS house-
hold survey. The fever density variable describes the
burden of fevers within the vicinity of each retailer. The
ratio of fever density to household density was also
calculated for each retailer to estimate the period preva-
lence of fevers around each shop. These three variables –
population density, fever density and prevalence in the
vicinity of each shop – describe the potential for local
demand. These variables were only calculated for retail
outlets located entirely within the HDSS. Household
characteristics – acres of land owned and whether a
family grows cash crops – were also used to make
density rasters and values were extracted to outlet loca-
tions. The percent of households growing cash crops,
level of education of the household head, and average
acres of land owned by households around each outlet
were used as proxies for wealth amongst the house-
holds closest to each. Density rasters and distance be-
tween neighbouring outlets and health facilities was
calculated in ArcMap 10 (ESRI).
Data analysis
The analyses investigated three major shop-level out-
come variables: the probability of stocking AL, the prob-
ability of stocking subsidized AL from the AMFm
programme, and the volume of three different types of
anti-malarials sold over the last week [AL, quinine, and
sulphadoxine-pyrimethamine (SP)]. The log of drug sales
volume was taken after adding one so that zero values
could be included in the analysis. The association be-
tween these outcome variables and the following factors
was examined: outlet size, quality, presence of nearby
competitors and population characteristics. Price of the
relevant drug was included when the outcome variable
was sales volume of anti-malarials. The overall size of
the retail outlet was measured by the total number of
staff and the total volume of all anti-malarials sold in the
last week. Quality was measured by the number of phar-
macists and nurses on staff and whether untrained staff
dispensed medications. The number of other medicine
retailers selling anti-malarials within 1 km was used as a
proxy for competition. Presence of a government facility
within 1 km and whether the nearest competitor sold
subsidized AL were included in the analysis. Population
characteristics for each outlet included household dens-
ity, fever density and prevalence, density of cash crop
farming, acres of land owned by households, and house-
hold head’s education.To estimate the relationship between price and volume
sold for each drug type, a regression model of the log of
sales volume on the log of the price was used, while con-
trolling for other factors that influence demand such as
the local disease burden and population density. Chi-
square tests and t-tests were used to explore the rela-
tionship between independent variables and retail outlet
characteristics. Multivariate normal and logistic regres-
sion models were estimated to determine factors that in-
fluence retailer’s decision to stock AL and subsidized
AL and factors that influence sales volume of the most
commonly stocked anti-malarials. P-values <0.10 were
considered significant due to the small number of out-
lets in the analysis. Analysis was done using Stata 11
(StataCorp).Ethical approval
The study was approved by the Moi University Institu-
tional Research and Ethics Committee and the Duke
University Institutional Review Board. Consent from
local community leaders and the Webuye Health and
Demographic Surveillance Site Scientific Steering Com-
mittee was also sought and granted.Results
Characteristics of medicine retail outlets stocking
anti-malarials
Ninety-seven outlets that regularly stocked and sold
anti-malarials were surveyed and included in the analysis
(Table 1). The median number of different brands of
anti-malarials per outlet was two (range 1–8), with 28
stocking a single brand of anti-malarial.
Supply-side factors collected through the survey in-
clude size of the outlet, training of the staff, and compe-
tition. The median number of neighbours within 1 km
was two, but ranged from zero to 12. A government fa-
cility was located within 1 km for 42.6% of the outlets.
The number of staff ranged from one to six and 62%
of retail outlets had only one staff member. On average,
shops sold ~20 courses of anti-malarials in the preceding
one-week period; 46.4% of shops had a nurse or nurse-
aide on staff and 39.2% had a pharmacist or pharmaceut-
ical technologist; 25% of shops had untrained staff (no
relevant training or education) dispensing drugs.
Demand-side factors including local population
density and fever burden were estimated for shops
within the HDSS (n = 33) by extracting local popula-
tion characteristics around each outlet. The mean
density of households (number per 0.8 sq km) around
an outlet was 108 and the mean number of fevers
within these households in the last six months was
22.8. The ratio of fevers to households (local period
prevalence per 0.8 sq km) was 0.23.
Table 1 Characteristics of surveyed outlets
Shop characteristics (n = 97)
Size
Mean volume sold per shop (SD) 19.7 (27.6)
Median number of drug brands per shop (range) 2 (1–8)
Median number of personnel (range) 1 (1–6)
Quality
Percent with a pharmacist or pharmaceutical technologist 46.4
Percent with a nurse or nurse aide 39.2
Percent with untrained personnel dispensing 25
Competition
Neighbours within 1 km (median, range) 2 (0–12)
Percent of shops within 1 km of government facility 42.6
Demand (n = 33)
Mean HH density around each shop (SD) 108 (80)
Mean fever density around each shop (SD) 22.8 (16.9)
Fever prevalence in households around each shop (SD) 0.23 (0.12)
Proportion of households with cash crop farming around each shop 25.1 (21.1)
Acres of land owned (average in HDSS) 1.8 (3.74)
Head education (all HDSS)
Primary or below 60.5%
Secondary 30.9%
Above secondary 8.6%
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to reflect purchasing power (acres of land owned, educa-
tion of the head and cash crop farming) were also
estimated around each outlet. On average, 23% of house-
holds within 0.8 sq km of outlets were cash crop farmers
and households owned on average 1.8 acres of land.
Overall, 39% of household heads had secondary educa-
tion or above.
The average price of a treatment course of AL was
2.73 USD and ranged from 0.38 to 7.50 USD. The aver-
age price for quinine (1.21 USD, range 0.25-5.63 USD)
and SP (0.65 USD, range 0.19-1.50 USD) was lower
than for AL. The geographic availability of SP and quin-
ine is much greater than for AL (Figure 1). Pockets of
AL availability coincide with peri-urban areas and mar-
ket centres where price heterogeneity is greater. How-
ever, lower prices for AL are found in areas where
shops are sparser.
Anti-malarial stocking practices
Some 22% of outlets stock any brand of AL, with a total
of 13 different brands observed. Table 2 reports un-
adjusted and adjusted odds ratios for the analysis of AL
and AMFm AL stocking practices. There was statistically
significant correlation between outlet characteristics and
whether or not they carried any brand of AL. Thenumber of other anti-malarial outlets in the vicinity in-
creased the likelihood of stocking AL as did the size of
the outlet, determined by both total staff and total anti-
malarial doses sold in the last week. Outlets with a
pharmacist on staff were far more likely to carry AL
(OR = 4.92; p < 0.01) whereas those with a nurse on staff
were less likely to carry AL (OR = 0.28; p < 0.01). In-
creasing numbers of households in the vicinity that
farmed cash crops slightly reduced the odds of stocking
AL (OR = 0.93, p = 0.024). In the multivariable model,
the size of the outlet (OR = 3.56; p = 0.02) and nearby
competition (OR = 1.13; p = 0.08) were correlated with
carrying any AL. Shop attendant training (pharmacist,
nurse or no training) was no longer statistically signifi-
cant when the effect was corrected for size of the outlet.
Eleven percent of retail medicine outlets in the survey
carried subsidized AL. In order to understand if the de-
terminants of stocking any AL were different than those
correlated with stocking subsidized AL, the analyses
were repeated looking at whether an outlet stocked sub-
sidized AL. Similar to the results for any AL, training
and size of the outlet were important predictors of
stocking subsidized AL. Having a pharmacist on staff
was also correlated with stocking subsidized AL. In
the multivariable model, total volume of anti-malarial
sales remained significantly but weakly correlated with
a b c
d e f
Figure 1 Map of study area showing sales volume and price of antimalarials in retail outlets of Bungoma East district. a, b, c. Sales
volume in the last one week for sulphadoxine-pyrimethamine, artemether lumefantrine and quinine, respectively. d, e, f. Price of sulphadoxine-
pyrimethamine, artemether lumefantrine, and quinine, respectively. The size of the circle scales with the magnitude of the variable depicted.
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appears to play a large role in determining whether
shops stock subsidized AL. Outlets whose nearest com-
petitor carried subsidized AL were six times more likely
to also carry subsidized AL (OR: 6.4; p = 0.09).
Sales volume and price
In order to analyse factors associated with the volume of
anti-malarials sold by an outlet, the log of volume sold
was used as the outcome variable. Other factors consid-
ered were similar to the analyses of stocking practices,
including competition, local household and fever density,
outlet size and staff training. The analysis was repeated
for the three most commonly stocked drugs – AL, SP
and quinine (Table 3).
In the unadjusted analysis, price was a statistically sig-
nificant predictor of sales volume for all three types ofdrugs – AL, SP and quinine – but the magnitude of the
relationship varied by drug type (Figure 2). The strongest
association between price and sales was found for SP
and the weakest association was found for quinine. The
negative co-efficient indicates that the volume of sales
was inversely related to price, as expected. In the multi-
variable model for SP, 1% increase in the price of SP
was associated with a 0.92% decrease in quantity sold
(p < 0.01). For AL, on the other hand, a 1% increase in
price was associated with a 0.44% decrease in quantity
sold (p = 0.19).
Competition was an important determinant of sales
volume for AL – the number of courses of AL sold de-
clines significantly if the nearest neighbour had AL.
Stores with more staff members sold more AL and SP,
but stores with trained staff sold less SP even when
correcting for size of the shop. Local household density
Table 2 Stocking artemether-lumefantrine and subsidized artemether-lumefantrine
Variable Stocking any AL Stocking AMFm AL
Unadjusted OR (p) Adjusted OR (p)* Unadjusted OR (p) Adjusted OR (p)
Size Number of staff 3.74 (p = 0.001) 3.56 (0.019) 1.92 (p = 0.049) 1.14 (0.78)
Total volume sold in last week 1.05 (p = 0.001) 1.04 (0.015) 1.04 (p = 0.001) 1.03 (0.03)
Quality Pharmacist on staff 4.92 (p = 0.000) 2.45 (0.215) 3.53 (p = 0.076) 1.49 (0.8)
Nurse on staff 0.28 (p = 0.005) 0.5 (0.375) 0.31 (p = 0.15) 0.52 (0.68)
Untrained staff dispensing medicine 0.76 (p = 0.57) - 0.69 (p = 0.65) 0.28 (0.4)
Competition Number of neighbours within 1 km 1.16 (p = 0.01) 1.13 (0.08) 1.05 (p = 0.6) 1.07 (0.52)
Nearest govt. facility within 1 km 1.19 (p = 0.68) 0.47 (0.20) 2.65 (p = 0.14) 0.69 (0.69)
Nearest neighbour has subsidized AL - 7.13 (p = 0.005) 6.4 (0.09)
Demand Household density 0.99 (p = 0.62) - -
Fever density 0.97 (0.25) - -
Fever prevalence in households 0.06 (p = 0.21) - -
Density of cash crop farming 0.93 (0.024) - -
Acres of land owned 0.99 (0.074) - -
Head education 0.99 (0.52) - -
*non-geographic variables only were used for the multivariable regression because the number of outlets within the DSS (n = 33) was much smaller than the
overall sample size.
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univariate analyses. Fever density was correlated with SP
sales (p = 0.089), but the result was marginally statisti-
cally significant.
Discussion
Results from this study show that, shortly after the roll-
out of the AMFm subsidy programme, larger outlets
with more staff, greater sales volume, and a pharmacist
on staff were more likely to stock AL and subsidized
AL. The presence of AL or subsidized AL in nearby out-
lets increased the odds of a shop selling AL and subsi-
dized AL. Shops with neighbours selling AL also sold
AL for lower prices. Overall, volume of anti-malarial
sales was not as dependent on price as expected, par-
ticularly for AL.
The retail sector is an important source of treatment
for fevers in malaria-endemic areas. Achieving the global
target of 80% of childhood fevers treated with an appro-
priate anti-malarial within 48 hours of onset [1] will not
be possible without involving the retail sector in many
settings. Pilot studies of anti-malarial subsidies demon-
strated significant improvements in the availability of
ACT in the retail sector and the percent of fevers being
treated with an effective anti-malarial [19,20]. In 2010,
the AMFm subsidy was launched in eight countries to
make effective ACT accessible and affordable in the re-
tail sector. A previous report from Kenya showed that
within just a few months of the launch in Kenya, subsi-
dized ACT was available in retail shops in rural, malaria-
endemic areas [7] and subsidized brands were markedly
less expensive than other ACT. However, the price ofAMFm-subsidized ACT still varied by nearly an order of
magnitude between shops and in only one shop was
AMFm-brand AL being offered at the recommended re-
tail price. The price heterogeneity between different
brands of the same drug, and even the same brands of
the same drug, was also observed for outdated anti-
malarials such as SP and quinine (Figure 1).
In a pilot study in Tanzania, 25% of retail outlets sell-
ing anti-malarials still did not stock ACT one year after
implementation of the subsidy [20]. The factors that are
correlated with stocking AL and subsidized AL shed
light on the potential for success of antimalarial subsid-
ies in the retail sector. The results in this paper are im-
portant for understanding how to improve uptake of
subsidized drugs amongst retail outlets and understand-
ing what other factors may increase the market share of
subsidized drugs.
There was a consistently negative association between
the price of drugs and shop-level sales of the drug. More
importantly, the co-efficient estimated indicated that
sales of anti-malarials were not extremely sensitive to
price. This was especially true for quinine and AL and
less so for SP. This was surprising given the wide range
of prices observed for the same class of drug. This may
be due to the fact that resource-poor households are
driven to obtain anti-malarials when their children have
a fever regardless of the price of these drugs (within a
reasonable price range). They may be self-financing their
purchases by reductions in consumption of other im-
portant items, such as food or transportation. The lack
of correlation between the price of quinine and SP with
doses sold challenges the assumption of the AMFm
Table 3 Relationship between sales volume, price and outlet characteristics
Theme Variable SP AL Quinine
Unadjusted
effect size (p)
Adjusted
effect size (p)
Unadjusted
effect size (p)
Adjusted
effect size (p)
Unadjusted
effect size (p)
Adjusted
effect size (p)
Price Log price −0.78 (0.002) −0.92 (0.000) −0.59 (0.02) −0.44 (0.19) −0.34 (0.02) −0.29 (0.15)
Size Number of staff 0.24 (0.25) 0.43 (0.06) 0.12 (0.51) 0.27 (0.09) 0.09 (0.48) 0.11 (0.55)
Quality Pharmacist on staff −0.02 (0.95) −1.15 (0.08) 0.40 (0.24) 1.06 (0.22) 0.36 (0.11) 0.15 (0.78)
Nurse on staff −0.49 (0.08) −1.57 (0.02) 0.040 (0.92) 0.69 (0.48) −0.24 (0.29) −0.5 (0.92)
Untrained staff dispensing medicine 0.67 (0.05) −0.47 (0.32) −0.13 (0.76) 0.16 (0.84) −0.09 (0.73) −0.19 (0.66)
Competition Number of neighbours within 1 km 0.03 (0.46) 0.05 (0.22) −0.06 (0.15) −0.04 (0.33) 0.004 (0.88) 0.002 (0.96)
Nearest govt. facility within 1 km −0.02 (0.95) −0.13 (0.64) 0.53 (0.14) 0.38 (0.21) 0.39 (0.08) 0.26 (0.37)
Nearest neighbour has subsidized AL 0.5 (0.86) 0.29 (0.51) −0.09 (0.34) −1.09 (0.06) 0.31 (0.94) 0.04 (0.04)
Demand Household density 0.01 (0.198) - 0.002 (0.88) - −0.002 (0.68) -
Fever density 0.053 (0.089) - 0.03 (0.59) - −0.007 (0.76) -
Fever prevalence in households 2.4 (0.59) - 15.1 (0.14) - −0.51 (0.90) -
Density of cash crop farming 0.01 (0.76) 0.016 (0.77) −0.03 (0.11)
Acres of land owned 0.002 (0.40) 0.01 (0.45) −0.003 (0.33)
Head education 0.004 (0.18) 0.002 (0.83) −0.001 (0.73)
n = 26 for geographic variables n = 11 for geographic variables n = 30 for geographic variables
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barrier to increasing their market share. The AMFm
subsidy will have to contend with the challenge of get-
ting households to switch away from older medications.
This is consistent with results from the AMFm evalu-
ation, which showed that availability of ACT in retail
shops was limited when implementation of supporting
interventions such as community awareness campaigns
was weak. On a country-wide scale, the availability of
AMFm ACT in the retail sector did not seem to be re-
lated to the median price of the AMFm ACT [21]. Thus,
price alone may not drive the success of the AMFm
programme, as demand for specific anti-malarials may
be dominated by other factors.
Few stores stocked AL or subsidized AL. Larger stores
with more staff and larger sales volumes, probably corre-
sponding to more rapid turnover of their inventory, are
more likely to stock AL and subsidized AL. Larger stores
may have more capital and can stock newer drugs or
drugs that do not sell as quickly. The ineffective, out-
dated anti-malarial SP is sold in higher volumes from
stores with untrained staff, even when correcting for the
size of the store. Larger stores sell more quinine and AL,
even when adjusting for price, but whether they have
trained staff such as a nurse or pharmacist does not
affect sales.
Similar to a study in Tanzania [22], the results
presented here demonstrate that competition affects the
likelihood of stocking subsidized AL. If the nearest com-
petitors stock subsidized AL, it increases the likelihood
of also stocking subsidized AL by six-fold. The strongestevidence for ascribing this to a competition effect comes
from the added observation that, on average, an outlet
sells less AL if the nearest neighbour has subsidized AL.
However, this analysis is based on cross-sectional data
and the availability of subsidized AL in individual shops
is not randomly determined. Therefore, it is possible that
confounding factors may influence whether neighbouring
shops have subsidized AL and the effect of having subsi-
dized AL may not necessarily represent the effect of com-
petition. Interestingly, being close to a government facility,
where AL is provided free of charge, did not seem to affect
stocking or sales of AL. If public health facilities rarely ex-
perience shortages of AL, it would be reasonable to as-
sume that stocking AL in nearby pharmacies would not
be particularly advantageous and demand would be low. If
health facilities have frequent shortages of AL, patients
may leave with a prescription for AL and pharmacies near
the facility may experience a high demand. Neither of
these effects were measured in this study. Promoting the
adoption of AL by selected outlets in various regions may
be an effective way to encourage broader adoption across
those regions.
Demand-side factors, such as local population dens-
ity, density of fevers and measures of wealth, did not
correlate with stocking and sales practice. Local fever
density was marginally associated with sales of SP. Pre-
vious studies have shown a relationship between cus-
tomer education, socio-economic status and purchasing
ACT. More educated, wealthier individuals were more
likely to purchase drugs at retail outlets with ACT, but
wealthier individuals were more likely to buy SP [22]. The
65
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Figure 2 Price versus sales volume for artemether lumefantrine,
sulphadoxine-pyrimethamine and quinine. Lines represent the
slope of co-efficient of log price in the multivariate logistic
regression models.
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http://www.malariajournal.com/content/12/1/186ability of this study to measure associations between
demand-side factors and sales may be compromised by
the small number of outlets falling within the population
surveillance area for which demand-side variables could
be assigned.
This study attempted to discern customer behaviour
and preferences, for example, what attracts customers to
specific outlets, from a supply-side survey. There are
many important demand-side factors that were not mea-
sured. For example, consumers may be reluctant to
switch from products with which they are familiar or
they may prefer the one-dose regimen of SP over the
six-dose, three-day treatment course of AL. Analysis of
household data, including information on socio-
economic indicators and treatment-seeking preferences
will be useful for better understanding anti-malarial pur-
chase decisions. In these analyses, sales volume was con-
sidered to be a dependent variable and price to be an
independent predictor of sales. In reality, price is not in-
dependent of sales volume and price may increase as de-
mand increases or vice versa. However, data for sales
volume in just the last one-week period was used. Over
such a short period, price could be expected to be rela-
tively independent of sales volume although over longer
periods, price certainly fluctuates with demand. Finally,
this analysis applies to outlets that sell primarily human
medicines, regardless of legal registration status, but ex-
cludes general stores that may sell anti-malarials in
addition to household goods. These stores may also in-
fluence demand and sales volume in this area, but they
have not been captured in the analysis.
Despite these limitations, some interesting recommen-
dations for retail-sector antimalarial subsidies emergefrom this analysis. Late or lack of adoption of subsidized
AL may be a shop-level constraint. It is possible that
small, rural stores with limited capital and low drug sales
cannot buy new drugs until current stocks are sold. One
possible remedy would be to provide an initial stock for
smaller stores, either at no cost or as a loan to be repaid
if the stock sells. Small stores may be risk averse and re-
luctant to stock newer drugs without knowing that they
will be bought. Advertising and promotion of AL
amongst both consumers and retailers could foster belief
among shop owners that this is a product for which
there will be adequate demand.
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